Clinical Trial Update: NovoLet® Acceptance Study Within the Hospital Practise in Indonesia

View source ↗

Summary

Update on a NovoLet acceptance trial conducted in Indonesian hospital practice; the study involving diabetes patients (Type 1 and Type 2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoLet (insulin human)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED